Product Information

GABAPENTIN 250 MG/5 ML SOLN is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0821 per ML under NDC 31722006947. Its NADAC has been published 116 times since Sep 4, 2024.

FDA first approved this application on Jan 17, 2024. Its Orange Book therapeutic-equivalence code is AA.

The High Outlier badge above means this manufacturer's average price in the GABAPENTIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GABAPENTIN 250 MG/5 ML SOLN

GABAPENTIN
$0.0821per ML
High Outlier

Strength

250 mg/5mL

NDC

31722006947

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA217682

FDA Approved

1/17/2024

TE Code

AA

On Market Since

1/17/2024

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 250 MG/5 ML SOLN has been published 116 times since Sep 4, 2024, and over the history we have for it it has declined 34.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0821 per ML
All-time high$0.1257 (Sep 11, 2024)
All-time low$0.0768 (Nov 20, 2024)
52-week high$0.0887
52-week low$0.0821
Median price$0.0868
Average price$0.0886
Largest weekly change-19.0% (Nov 20, 2024)
Weeks tracked116
Tracking sinceSep 4, 2024

Price History

1W

-2.2%

1M

-6.3%

3M

-7.4%

6M

-2.1%

1Y

-5.4%

3Y

N/A

5Y

N/A

All

-34.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the GABAPENTIN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 250 MG/5 ML SOLN?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 250 MG/5 ML SOLN, manufactured by Camber Pharmaceuticals Inc., is $0.0821 per ML (NDC 31722006947), effective Nov 18, 2026.

How has the price of GABAPENTIN 250 MG/5 ML SOLN changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has declined 34.7%. It has been tracked across 116 weekly CMS publications since Sep 4, 2024.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 250 MG/5 ML SOLN?

Since Sep 4, 2024, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has ranged from a low of $0.0768 (Nov 20, 2024) to a high of $0.1257 (Sep 11, 2024), with a median of $0.0868 per ML.

Are there cheaper alternatives to GABAPENTIN 250 MG/5 ML SOLN?

No other NADAC-published product currently shares the active ingredient and strength of GABAPENTIN 250 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GABAPENTIN 250 MG/5 ML SOLN?

GABAPENTIN 250 MG/5 ML SOLN (NDC 31722006947) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.